Correlation Between Cresud SACIF and Celltrion Pharm

Can any of the company-specific risk be diversified away by investing in both Cresud SACIF and Celltrion Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cresud SACIF and Celltrion Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cresud SACIF y and Celltrion Pharm, you can compare the effects of market volatilities on Cresud SACIF and Celltrion Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cresud SACIF with a short position of Celltrion Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cresud SACIF and Celltrion Pharm.

Diversification Opportunities for Cresud SACIF and Celltrion Pharm

-0.7

Correlation Coefficient

Cresud SACIF  Celltrion Pharm

Excellent diversification

The 3 months correlation between Cresud and Celltrion is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Cresud SACIF y and Celltrion Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celltrion Pharm and Cresud SACIF is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cresud SACIF y are associated (or correlated) with Celltrion Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celltrion Pharm has no effect on the direction of Cresud SACIF i.e., Cresud SACIF and Celltrion Pharm go up and down completely randomly.

Pair Corralation between Cresud SACIF and Celltrion Pharm

Assuming the 90 days horizon Cresud SACIF y is expected to under-perform the Celltrion Pharm. But the stock apears to be less risky and, when comparing its historical volatility, Cresud SACIF y is 1.43 times less risky than Celltrion Pharm. The stock trades about -0.07 of its potential returns per unit of risk. The Celltrion Pharm is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  5,504,762  in Celltrion Pharm on October 4, 2024 and sell it today you would lose (24,762) from holding Celltrion Pharm or give up 0.45% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	95.45%
Values	Daily Returns

Cresud SACIF y  vs.  Celltrion Pharm

Cresud SACIF y

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Cresud SACIF y are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Cresud SACIF showed solid returns over the last few months and may actually be approaching a breakup point.

Celltrion Pharm

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Celltrion Pharm has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Cresud SACIF and Celltrion Pharm

The main advantage of trading using opposite Cresud SACIF and Celltrion Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cresud SACIF position performs unexpectedly, Celltrion Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celltrion Pharm will offset losses from the drop in Celltrion Pharm's long position.

The idea behind Cresud SACIF y and Celltrion Pharm pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.